Previous close | 232.25 |
Open | 235.00 |
Bid | 231.99 x 800 |
Ask | 235.25 x 1000 |
Day's range | 230.59 - 235.56 |
52-week range | 224.02 - 281.16 |
Volume | |
Avg. volume | 1,531,860 |
Market cap | 88.129B |
Beta (5Y monthly) | 1.00 |
PE ratio (TTM) | 44.31 |
EPS (TTM) | 5.26 |
Earnings date | 25 Jul 2022 - 29 Jul 2022 |
Forward dividend & yield | 2.78 (1.20%) |
Ex-dividend date | 29 Jun 2022 |
1y target est | 283.00 |
Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.
PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies (“AeroClean” or the “Company”) (Nasdaq: AERC), a pathogen elimination technology company harnessing patented UV-C LED technology with Pūrgo™ to significantly reduce and remove harmful pathogens to keep work, play and life going, today announced the appointment of Timothy J. Scannell, former President and Chief Operating Officer at Stryker, to its Board of Directors (the “Board”). On May 11, 2022, the Board appointe
The big shareholder groups in Stryker Corporation ( NYSE:SYK ) have power over the company. Generally speaking, as a...